Voglital 0.2 Tablet
Marketer
Talent India
Salt Composition
Voglibose (0.2mg)
Overview Voglital 0.2 Tablet
Diabetac 0.2mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating postprandial hyperglycemia. It's indicated when dietary modifications and other comparable medications prove insufficient in controlling elevated blood glucose. Diabetac 0.2mg tablets should be administered immediately prior to meals. Dosage and frequency are determined by your physician to optimize blood sugar control. Discontinue use only under your doctor's guidance; abrupt cessation can lead to dangerously high blood sugar, potentially resulting in serious complications such as renal impairment and vision loss. This treatment forms part of a comprehensive program encompassing diet, exercise, and weight management as directed by your physician. Regular blood glucose monitoring is essential. Common adverse reactions may include gas, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Diabetac 0.2mg tablets themselves do not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your doctor of any liver or kidney issues before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals require medical consultation prior to use. Ensure your doctor is aware of all other medications you are taking to prevent interactions. Excessive alcohol consumption should be avoided due to the increased hypoglycemia risk.
Uses of Voglital 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Voglital 0.2 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglital 0.2 Tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Voglital 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglital 0.2 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglital 0.2mg tablets should be taken on an empty stomach.
How Voglital 0.2 Tablet works:
Diabetics may use Voglital 0.2mg tablets to manage their condition. This medication works by blocking enzymes in the intestines that digest complex carbohydrates. Consequently, post-meal blood sugar spikes are reduced.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglital 0.2 Tablets with alcohol is strongly discouraged due to safety concerns.
PregnancySAFE IF PRESCRIBED
Using Voglital 0.2 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using Voglital 0.2 Tablet while breastfeeding appears to be safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglital 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Voglital 0.2 Tablet cautiously. Dosage modification for Voglital 0.2 Tablet may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Voglital 0.2 Tablet, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Voglital 0.2 Tablet :
Omit any missed Voglital 0.2 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Voglital 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Alpha-glucosidase inhibitors |



